3 April 2023 in Climacteric
In the last 20 years, the prevalence of type 2 diabetes mellitus (T2DM) has tripled in adults aged 20–79 years, affecting more than 25% of people over 50 years of age and especially women during menopause. After the menopause transition, women gain weight, increasing abdominal fat and decreasing lean body mass, with a significant reduction in energy expenditure. Increased insulin resistance and hyperinsulinism characterize this period, aggravated by an increase in plasma proinflammatory cytokines and free fatty acids, and a state of relative hyperandrogenism. Previous recommendations systematically excluded women with T2DM from menopause hormone therapy (MHT); new evidence confirms that MHT significantly reduces the diagnosis of new-onset T2DM and may be beneficial in terms of glycemic control when used for menopause symptom management in patients with pre-existing T2DM. A comprehensive and individualized approach is considered the first line of management for women during this period, especially in T2DM patients or in women at risk of developing the disease. The objectives of this presentation are to review the etiopathogenic factors involved in the increased incidence of new cases of T2DM during menopause, the impact of menopause on T2DM and the role of MHT.
8 June 2024 in Archives of Osteoporosis
Introduction: These guidelines aim to provide evidence-based recommendations for the supplementation of Vitamin D in maintaining bone health. An unmet need persists in Latin American regarding the availability of clinical and real-world data for rationalizing the use of vitamin D supplementation. The objective of these guidelines is to establish clear and practical recommendations for healthcare practitioners from Latin American countries to address Vitamin D insufficiency in clinical practice. Methods: The guidelines were developed according to the GRADE-ADOLOPMENT methodology for the adaptation or adoption of CPGs or evidence-based recommendations. A search for high quality CPGs was complemented through a comprehensive review of recent literature, including randomized controlled trials, observational studies, and systematic reviews evaluating the effects of Vitamin D supplementation on bone health. The evidence to decision framework proposed by the GRADE Working Group was implemented by a panel of experts in endocrinology, bone health, and clinical research. Results: The guidelines recommend Vitamin D supplementation for individuals aged 18 and above, considering various populations, including healthy adults, individuals with osteopenia, osteoporosis patients, and institutionalized older adults. These recommendations offer dosing regimens depending on an individualized treatment plan, and monitoring intervals of serum 25-hydroxyvitamin D levels and adjustments based on individual results. Discussion: The guidelines highlight the role of Vitamin D in bone health and propose a standardized approach for healthcare practitioners to address Vitamin D insufficiency across Latin America. The panel underscored the necessity for generating local data and stressed the importance of considering regional geography, social dynamics, and cultural specificities when implementing these guidelines.
19 May 2021 in Climacteric
Osteoporosis is a highly prevalent systemic skeletal disorder leading to decreased bone strength and increased susceptibility to fragility fracture. The global burden of osteoporosis negatively impacts health systems around the world, and the estimation of millions of individuals at high risk for fracture in 2010 will double by the year 2040. There are many techniques to evaluate bone mineral density, but the preferred method in clinical practice is dual-energy X-ray absorptiometry (DXA). This method, despite offering multiple advantages, can lead us to a wrong diagnosis if we do not take into account certain clinical and technical considerations. The objective of this review is to analyze the different aspects that we must consider when, as clinicians, we have to evaluate a densitometric report. These aspects are presented as technical factors influencing DXA results and patients’ conditions limiting DXA interpretation.
3 February 2026 in Archives of Osteoporosis
Summary: A country-specific FRAX® model for Costa Rica was developed using national hip fracture data from 2015–2019. Hip fracture incidence increased with age, was consistently higher in women, and exceeded rates reported in neighboring Latin American countries. Costa Rica also demonstrated higher 10-year major osteoporotic fracture probabilities at older ages compared with regional FRAX® models. An estimated 3,176 hip fractures occurred in 2020, with projections indicating an increase to 9,946 cases by 2050. These findings underscore the growing burden of hip fractures in Costa Rica and the need for targeted prevention strategies. Objective: To describe the epidemiology of hip fractures in Costa Rica and to develop a country-specific FRAX® model calibrated with national fracture and mortality data. Methods: All hip fractures (ICD-10 S72.0, S72.1, S72.2) recorded in the Caja Costarricense de Seguro Social registry from 2015–2019 were included. Age- and sex-specific incidence rates were combined with United Nations mortality data to construct a Costa Rica–specific FRAX® model. Ten-year fracture probabilities were estimated and compared with those from other Latin American countries with calibrated FRAX® models. National projections for hip fracture burden in 2020 and 2050 were derived using United Nations population forecasts. Age-specific FRAX® assessment and intervention thresholds were developed following established international methodology. Results: Hip fracture incidence increased with age and was consistently higher in women than in men. Compared with other Latin American countries, Costa Rica demonstrated higher age-specific hip fracture rates and higher 10-year major osteoporotic fracture probabilities at older ages. An estimated 3,176 hip fractures occurred in adults aged ≥ 50 years in 2020, with a projected increase to 9,946 by 2050. Age-specific FRAX® threshold curves showed widening separation with advancing age, reflecting increasing fracture probability in older age groups. Conclusion: Costa Rica exhibits a comparatively high burden of hip fractures and fracture risk, which is expected to rise substantially with population aging. The newly developed Costa Rica–specific FRAX® model provides an essential tool for improving fracture risk assessment and guiding evidence-based osteoporosis management in clinical practice.